ESTRAGUARD Drug Patent Profile
✉ Email this page to a colleague
When do Estraguard patents expire, and when can generic versions of Estraguard launch?
Estraguard is a drug marketed by Solvay and is included in one NDA.
The generic ingredient in ESTRAGUARD is dienestrol. There is one drug master file entry for this compound. Additional details are available on the dienestrol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ESTRAGUARD?
- What are the global sales for ESTRAGUARD?
- What is Average Wholesale Price for ESTRAGUARD?
Summary for ESTRAGUARD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Patent Applications: | 2,186 |
| DailyMed Link: | ESTRAGUARD at DailyMed |
US Patents and Regulatory Information for ESTRAGUARD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | ESTRAGUARD | dienestrol | CREAM;VAGINAL | 084436-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
